NAD+ metabolism is a key modulator of bacterial respiratory epithelial infections

Nat Commun. 2023 Oct 2;14(1):5818. doi: 10.1038/s41467-023-41372-w.

Abstract

Lower respiratory tract infections caused by Streptococcus pneumoniae (Spn) are a leading cause of death globally. Here we investigate the bronchial epithelial cellular response to Spn infection on a transcriptomic, proteomic and metabolic level. We found the NAD+ salvage pathway to be dysregulated upon infection in a cell line model, primary human lung tissue and in vivo in rodents, leading to a reduced production of NAD+. Knockdown of NAD+ salvage enzymes (NAMPT, NMNAT1) increased bacterial replication. NAD+ treatment of Spn inhibited its growth while growth of other respiratory pathogens improved. Boosting NAD+ production increased NAD+ levels in immortalized and primary cells and decreased bacterial replication upon infection. NAD+ treatment of Spn dysregulated the bacterial metabolism and reduced intrabacterial ATP. Enhancing the bacterial ATP metabolism abolished the antibacterial effect of NAD+. Thus, we identified the NAD+ salvage pathway as an antibacterial pathway in Spn infections, predicting an antibacterial mechanism of NAD+.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenosine Triphosphate
  • Bacterial Infections*
  • Cell Line
  • Cytokines / metabolism
  • Humans
  • NAD / metabolism
  • Nicotinamide-Nucleotide Adenylyltransferase* / metabolism
  • Proteomics
  • Respiratory Tract Infections*

Substances

  • NAD
  • Cytokines
  • Adenosine Triphosphate
  • NMNAT1 protein, human
  • Nicotinamide-Nucleotide Adenylyltransferase